ACTIVE

STEKENE PHARMA

Export PDF

Financial year 2025 · closed on 31/12/2025

Net result

51,8 k €

+107.4% YoY

Gross margin

265,7 k €

+14.4% YoY

Equity

485,5 k €

+11.9% YoY

Workforce

1,7 ETP

-5.6% YoY

What does STEKENE PHARMA do?

STEKENE PHARMA is a Private limited company incorporated in 2000. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Stekene. It employs on average 1,7 ETP workers (FTE).

Legal situation

● Normal situation

BCE/KBO no. / VAT

BE 0473.402.164

Incorporation

01/12/2000

Legal form

Private limited company

Registered office

Kerkstraat(STE) 64
9190 Stekene · FlandreSee on map

Contributed capital

12 400,00 €

Latest accounts

31/12/2025

Average workforce

1,7 ETP

Activities (NACE)

47730Dispensing chemist in specialised stores· main 47730Dispensing chemist in specialised stores 52310Warehousing and support activities for transportation

Joint committees (1)

Signals

ProfitableSolid equityPositive cashflowPositive EBITDAHealthy social debts

View the BCE/KBO Public Search record →

Health score

Available with a Rovalta subscriptionTry for 7 days

Recommended credit limit

✦ Verdict · Analyst summary

Financials

Trend over 20 financial years

	2025		2024		2023		2022		2021		2020		2019		2018		2017		2016		2015		2014		2013		2012		2011		2010		2009		2008		2007		2006
Income statement
Gross margin	265,7 k €	+14.4%	232,2 k €	+20.7%	192,4 k €	-7.3%	207,5 k €	-6.8%	222,6 k €	+13.5%	196,1 k €	+15.7%	169,5 k €	-10.4%	189,1 k €	+45.8%	129,6 k €	-19.6%	161,3 k €	-18.7%	198,5 k €	-8.8%	217,5 k €	-8.0%	236,5 k €	-4.0%	246,4 k €	-6.5%	263,5 k €	+1.8%	258,7 k €	+16.9%	221,4 k €	-29.4%	313,5 k €	+8.8%	288,2 k €	+40.5%	205,2 k €
EBITDA	138,1 k €	+25.8%	109,8 k €	+23.2%	89,1 k €	-22.2%	114,6 k €	+6.9%	107,2 k €	+6.8%	100,3 k €	+79.3%	56 k €	+137%	23,6 k €	+534%	-5,4 k €	-113%	40,6 k €	-12.4%	46,4 k €	-13.4%	53,5 k €	-43.3%	94,4 k €	+6.7%	88,5 k €	-17.1%	106,7 k €	+2.9%	103,7 k €	+112%	48,9 k €	-73.9%	187,2 k €	+7.2%	174,5 k €	+54.2%	113,2 k €
Operating result	81,1 k €	+49.8%	54,2 k €	+57.5%	34,4 k €	-44.6%	62 k €	+14.6%	54,1 k €	+56.5%	34,6 k €	+385%	-12,1 k €	+72.4%	-44 k €	+32.8%	-65,4 k €	-414%	20,8 k €	-27.8%	28,8 k €	-24.4%	38,1 k €	-52.3%	80 k €	+7.5%	74,4 k €	-19.3%	92,2 k €	+33.8%	68,9 k €	+409%	13,5 k €	-88.4%	116,7 k €	-9.8%	129,3 k €	+97.8%	65,4 k €
Net result	51,8 k €	+107%	25 k €	+139%	10,5 k €	-79.8%	51,9 k €	+5.7%	49,1 k €	+70.8%	28,7 k €	+248%	-19,4 k €	+63.8%	-53,5 k €	+26.8%	-73,1 k €	-716%	11,9 k €	-51.3%	24,4 k €	-10.9%	27,4 k €	-49.4%	54,1 k €	+11.4%	48,6 k €	-16.7%	58,3 k €	+44.0%	40,5 k €	+4785%	829 €	-98.3%	48,6 k €	-20.2%	60,9 k €	+354%	13,4 k €
Balance sheet
Equity	485,5 k €	+11.9%	433,7 k €	+6.1%	408,7 k €	+2.6%	398,2 k €	+15.0%	346,3 k €	+16.5%	297,2 k €	+10.7%	268,5 k €	-6.7%	287,8 k €	-15.7%	341,3 k €	-17.6%	414,4 k €	+2.9%	402,5 k €	+6.4%	378,2 k €	+7.8%	350,8 k €	+18.2%	296,7 k €	+19.6%	248,1 k €	+30.7%	189,8 k €	+27.1%	149,3 k €	+0.6%	148,5 k €	+48.7%	99,9 k €	+157%	38,9 k €
Total assets	898,8 k €	-1.5%	912,5 k €	-6.6%	977 k €	+1.4%	963,1 k €	-3.6%	999 k €	-1.5%	1 M €	-6.7%	1,1 M €	-7.6%	1,2 M €	-2.0%	1,2 M €	+13.9%	1,1 M €	+20.3%	876,5 k €	+39.5%	628,3 k €	+3.5%	606,9 k €	+0.6%	603,2 k €	-10.4%	673,2 k €	+27.8%	526,7 k €	-19.5%	654,3 k €	+15.2%	568 k €	-7.2%	612,1 k €	+6.8%	573 k €
Cash	13,2 k €	-5.0%	13,8 k €	-1.8%	14,1 k €	-37.7%	22,6 k €	+46.7%	15,4 k €	+61.6%	9,5 k €	-35.9%	14,9 k €	+128%	6,5 k €	-56.6%	15 k €	-29.1%	21,2 k €	+90.1%	11,2 k €	-33.0%	16,7 k €	+19.9%	13,9 k €	-12.9%	15,9 k €	-14.0%	18,5 k €	-85.3%	125,8 k €	-52.3%	263,4 k €	+132%	113,7 k €	+14.3%	99,4 k €	+68.1%	59,1 k €
Debts	413,3 k €	-13.7%	478,8 k €	-15.7%	568,3 k €	+0.6%	564,9 k €	-13.5%	652,7 k €	-9.0%	717 k €	-12.4%	818,7 k €	-7.9%	888,9 k €	+3.4%	859,9 k €	+34.3%	640 k €	+35.0%	474 k €	+89.5%	250,1 k €	-2.3%	256,1 k €	-16.4%	306,4 k €	-27.9%	424,9 k €	+26.6%	335,8 k €	-33.3%	503,1 k €	+27.6%	394,1 k €	-19.3%	488,3 k €	-5.2%	515,2 k €
Other
Workforce	1,7 ETP	-5.6%	1,8 ETP	+12.5%	1,6 ETP	-5.9%	1,7 ETP	-10.5%	1,9 ETP	0.0%	1,9 ETP	0.0%	1,9 ETP	-26.9%	2,6 ETP	-25.7%	3,5 ETP	+40.0%	2,5 ETP	0.0%	2,5 ETP	0.0%	2,5 ETP	0.0%	2,5 ETP	0.0%	2,5 ETP	0.0%	2,5 ETP	-3.8%	2,6 ETP	-10.3%	2,9 ETP	+16.0%	2,5 ETP	+4.2%	2,4 ETP	+20.0%	2,0 ETP

Estimate

Indicative valuation

As an indication, this company is worth

between 500 k€ and 1 M€

See the valuation

Governance

Board of directors

Seen on filing of 31/12/2025 · 2 active · 10 ended

Active mandates

ALEXO

Chairman of the board of directors · since 01 septembre 2022 · 0870.896.286

Represented by Olivier Delaere

Active

SODIAP

Managing director · since 22 décembre 2020 · 0405.366.364

Represented by Tom Goderis

Active

Ended mandates

ARISTO

Chairman of the board of directors · since 22 décembre 2020 · until 31 août 2022 · 0434.718.564

Represented by Frank Coene

Ended

ARISTO

Chairman of the board of directors · since 22 décembre 2020 · 0434.718.564

Represented by Frank Coene

Ended

Frank Coene

Manager · since 01 janvier 2009 · until 22 décembre 2020

Ended

Frank Coene

Manager · since 01 janvier 2009

Ended

Annual accounts

Full financial information

	2025	2024	2023	2022	2021	2020
Type of account	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model
Start of the financial year	01/01/2025	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020
Closing of the financial year	31/12/2025	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	12/05/2026	16/06/2025	11/06/2024	09/06/2023	07/06/2022	14/06/2021
General meeting	10/04/2026	11/04/2025	12/04/2024	14/04/2023	08/04/2022	09/04/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days

Filings

Annual accounts filings

20 filings with the NBB

Model	Closing	General meeting	Filed	Language	Document
Abridged model	31/12/2025	10/04/2026	12/05/2026	Dutch	PDF
Abridged model	31/12/2024	11/04/2025	16/06/2025	Dutch	PDF
Abridged model	31/12/2023	12/04/2024	11/06/2024	Dutch	PDF
Abridged model	31/12/2022	14/04/2023	09/06/2023	Dutch	PDF
Abridged model	31/12/2021	08/04/2022	07/06/2022	Dutch	PDF
Abridged model	31/12/2020	09/04/2021	14/06/2021	Dutch	PDF
Abridged model	31/12/2019	10/04/2020	13/07/2020	Dutch	PDF
Abridged model	31/12/2018	12/04/2019	09/07/2019	Dutch	PDF
Abridged model	31/12/2017	13/04/2018	28/06/2018	Dutch	PDF
Abridged model	31/12/2016	14/04/2017	10/07/2017	Dutch	PDF
Abridged model	31/12/2015	08/04/2016	13/07/2016	Dutch	PDF
Abridged model	31/12/2014	10/04/2015	30/07/2015	Dutch	PDF
Abridged model	31/12/2013	11/04/2014	21/08/2014	Dutch	PDF
Abridged model	31/12/2012	12/04/2013	27/08/2013	Dutch	PDF
Abridged model	31/12/2011	13/04/2012	17/07/2012	Dutch	PDF
Abridged model	31/12/2010	08/04/2011	22/08/2011	Dutch	PDF
Abridged model	31/12/2009	09/04/2010	07/05/2010	Dutch	PDF
Abridged model	31/12/2008	26/06/2009	17/12/2009	Dutch	PDF
Abridged model	31/12/2007	27/06/2008	28/08/2008	Dutch	PDF
Abridged model	31/12/2006	29/06/2007	10/07/2007	Dutch	PDF

Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 500 k€ and 1 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2025 · 2 active · 10 ended

Active mandates

ALEXO

Chairman of the board of directors · since 01 septembre 2022 · 0870.896.286

Represented by Olivier Delaere

Active

SODIAP

Managing director · since 22 décembre 2020 · 0405.366.364

Represented by Tom Goderis

Active

Ended mandates

ARISTO

Chairman of the board of directors · since 22 décembre 2020 · until 31 août 2022 · 0434.718.564

Represented by Frank Coene

Ended

ARISTO

Chairman of the board of directors · since 22 décembre 2020 · 0434.718.564

Represented by Frank Coene

Ended

Frank Coene

Manager · since 01 janvier 2009 · until 22 décembre 2020

Ended

Frank Coene

Manager · since 01 janvier 2009

Ended

Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette

Belgian Official Gazette publications

Mandates23/07/2026
ONTSLAGEN - BENOEMINGEN
PDF
Mandates02/12/2022
ONTSLAGEN - BENOEMINGEN
PDF
Mandates07/01/2021
STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - WIJZIGING RECHTSVORM - ONTSLAGEN - BENOEMINGEN
PDF
Other05/05/2009
BENAMING - BOEKJAAR - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, )
PDF
Mandates23/01/2009
ONTSLAGEN - BENOEMINGEN
PDF
Capital / shares27/02/2004
ALGEMENE VERGADERING - KAPITAAL - AANDELEN - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, )
PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

2025
Annual accounts 202551,8 k €↑
2024
Annual accounts 202425 k €↑
2024
Name change018 - Stekene Pharma
2023
Annual accounts 202310,5 k €↓
2022
Annual accounts 202251,9 k €↑
2021
Annual accounts 202149,1 k €↑
2021
Name changeStekene Pharma
2020
Annual accounts 202028,7 k €↑
2019
Annual accounts 2019-19,4 k €↑
2018
Annual accounts 2018-53,5 k €↑
2017
Annual accounts 2017-73,1 k €↓
2016
Annual accounts 201611,9 k €↓
2015
Annual accounts 201524,4 k €↓
2014
Annual accounts 201427,4 k €↓
2013
Annual accounts 201354,1 k €↑
2012
Annual accounts 201248,6 k €↓
2011
Annual accounts 201158,3 k €↑
2010
Annual accounts 201040,5 k €↑
2009
Annual accounts 2009829 €↓
2008
Annual accounts 200848,6 k €↓
2007
Annual accounts 200760,9 k €↑
2006
Annual accounts 200613,4 k €
01/12/2000
IncorporationPrivate limited company

10/15	1 240 000	1 180 000	1 050 000
70	8 630 000	8 120 000	7 940 000
9904	412 000	388 000	301 000
17/49	2 970 000	3 140 000	3 380 000
9087	24,3	23,1	21,8

STEKENE PHARMA

Overview

What does STEKENE PHARMA do?

Trend over 20 financial years

Indicative valuation

Board of directors

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline